Cognigenics

About:

Cognigenics transforms mental health in the genetic age through cognitive neuroengineering.

Website: http://cognigenics.io

Top Investors: Lionheart Ventures

Description:

Cognigenics transforms mental health in the genetic age through cognitive neuroengineering. The company’s business is cognitive neuroengineering, which is the genetic engineering of desirable cognitive traits, such as mindfulness, relaxation, and mental acuity. These cognitive assets can enhance human performance in normal individuals or offset cognitive deficits in people suffering from mental health issues such as stress, anxiety, and depression (which are the initial applications).

Total Funding Amount:

$1.59M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Eagle, Idaho, United States

Founded Date:

2019-06-26

Contact Email:

office(AT)cognigenics.co

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-08-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai